Veeran Gowda Kadajji, holds a PhD in Pharmaceutical sciences. In his current role, he leads drug product development group at J-STAR Research in Cranbury, NJ. He has close to...
Dr. Qi Gao is a Distinguished Research Fellow of J-Star Research. She received a B.S. degree in Chemical Engineering and Materials Science from Tsinghua University and a Ph.D. in...
Dr. Kaushalendra Chaturvedi is a Sr. Research Scientist at J-Star Research Inc., in the Center for Pharma Crystallization (CfPC) and Drug Product Development group (DPD). His research is focused...
Dr. Grosso is the Senior Vice President of R&D Technical Operations at Arvinas Inc. He is responsible for active ingredient and drug product development, scale-up, manufacturing, and clinical supply...
Founder, SVP and CTO Center for Pharma Crystallization, J-Star Research ½Porton Pharma Solutions Dr. Jian Wang has 30 years of R&D experience in API crystallization, reaction and process engineering,...
Harsh S. Shah is working as a senior scientist at J-Star Research Inc. (Cranbury, NJ), where he leads “fit-to-purpose” research projects in drug discovery and drug product development. He...
Dr. Sun is Professor of Pharmaceutics in the Department of Pharmaceutics, University of Minnesota, USA. Dr. Sun’s research focuses on formulation development of tablet products through appropriate application of...
By Prof. Changquan Calvin Sun, Pharmaceutical Materials Science and Engineering Laboratory, University of Minnesota The development of a quality tablet product requires overcoming deficiencies in pharmaceutical properties of an...
Mr Brian Samas is an industrial scientist with over 22 years of experience at Pfizer Inc. Currently he holds a position of Sr. Principal Scientist in the Materials Science...
By Mr. Brian Samas, Pfizer Molecule XXIII is the most experimentally characterized crystal structure prediction (CSP) blind test molecule to date. Crystal structures of five polymorphs are presented with...
